T2 Biosystems, Inc. (TTOO) Q3 2022 Earnings Call Transcript

Nov. 10, 2022 8:02 PM ETT2 Biosystems, Inc. (TTOO)6 Comments
SA Transcripts profile picture
SA Transcripts

T2 Biosystems, Inc. (NASDAQ:TTOO) Q3 2022 Results Conference Call November 10, 2022 4:30 PM ET

Company Participants

Emma Poalillo - IR, Gilmartin Group

John Sperzel - Chairman, CEO

John Sprague - CFO

Brett Giffin - CCO

Conference Call Participants

Kyle Mikson - Canaccord

Vidyun Bais - BTIG

Steve Brozak - WBB


Ladies and gentlemen, welcome to the T2 Biosystems Incorporated Third Quarter 2022 Earnings Conference Call.

Your host for today, Emma Poalillo. You might now begin.

Emma Poalillo

Thank you, operator. I would like to remind everyone that comments made by management today and answers to questions will include forward-looking statements. Those include statements related to T2 Biosystems' future financial and operating results and plans for developing and marketing new products.

Forward-looking statements are based on estimates and assumptions as of today and are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied by these statements including the risks and uncertainties described in T2 Biosystems' annual report on Form 10-K filed with the SEC on March 23, 2022, and other filings the company makes with the SEC from time to time. The company undertakes no obligation to publicly update or revise any forward-looking statements, except as required by law.

With that, I would like to turn the call over to Chairman and CEO, John Sperzel. John?

John Sperzel

Thank you all for joining our third quarter 2022 earnings call. Today, I will review the company's performance during the third quarter, highlighting a number of recent accomplishments and discuss the progress we are making across our 3 corporate priorities. I will then turn the call over to John Sprague, our Chief Financial Officer, who will review our third quarter financial results before I provide some closing remarks and we open the call for questions and answers.

Recommended For You

Comments (6)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.